| 1 |
32612532 | Preparation of RGD Peptide/Folate Acid Double-Targeted Mesoporous Silica Nanoparticles and Its Application in Human Breast Cancer MCF-7 Cells. | 2020 |
1 |
| 2 |
27819026 | Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging. | 2016 |
1 |
| 3 |
25608113 | Conjugated polymer and drug co-encapsulated nanoparticles for chemo- and photo-thermal combination therapy with two-photon regulated fast drug release. | 2015 Feb 21 |
1 |
| 4 |
26349490 | Molecular Imaging of Breast Cancer: Role of RGD Peptides. | 2015 |
1 |
| 5 |
25075548 | Self-assembled nanoparticles based on PEGylated conjugated polyelectrolyte and drug molecules for image-guided drug delivery and photodynamic therapy. | 2014 Sep 10 |
1 |
| 6 |
19225614 | A photostable fluorescent probe for targeted imaging of tumour cells possessing integrin alpha(v)beta(3). | 2009 Mar |
1 |
| 7 |
19273106 | Application of RGD-containing peptides as imaging probes for alphavbeta3 expression. | 2009 Jan 1 |
1 |
| 8 |
19719118 | Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. | 2009 Dec |
1 |
| 9 |
16472190 | Multimodality imaging of tumor integrin alphavbeta3 expression. | 2006 Feb |
1 |
| 10 |
17009846 | Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. | 2006 Sep-Oct |
1 |
| 11 |
15530369 | Structural insights into how the MIDAS ion stabilizes integrin binding to an RGD peptide under force. | 2004 Nov |
1 |
| 12 |
20641240 | 4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(S)-[N-3-amino-(SCN-Bz-DOTA-111In)-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine | 2004 |
1 |
| 13 |
20641284 | Arginine-glycine-aspartic acid peptide-labeled quantum dot 705 | 2004 |
1 |
| 14 |
20641361 | 4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(S)-[N-3-amino-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine fluorescein thiourea | 2004 |
1 |
| 15 |
20641375 | N-[2-(4-[18F]Fluorobenzamido)ethyl]maleimide-sulfhydryl-cyclic-arginine-glycine-aspartic acid dimeric peptide | 2004 |
1 |
| 16 |
20641381 | Cy7-Tetrameric arginine-glycine-aspartic acid peptide | 2004 |
1 |
| 17 |
20641437 | [18F]FB-NH-mini-PEG-E{E[c(RGDyK)]2}2 | 2004 |
1 |
| 18 |
20641687 | 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-PEGylated dimeric cyclic arginine-glycine-aspartic acid peptide | 2004 |
1 |
| 19 |
20641766 | 64Cu-Anti-human integrin αvβ3 monoclonal antibody | 2004 |
1 |
| 20 |
22457887 | 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,710,13-tetraoxapentadecanoic acid) | 2004 |
1 |
| 21 |
22457888 | 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid) | 2004 |
1 |
| 22 |
22457890 | 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid) | 2004 |
1 |
| 23 |
22934321 | 111In-Labeled multifunctional single-attachment-point reagent-c[RGDfK] | 2004 |
1 |